Comparably Top CEOs Brooke LeVasseur

USA Today: AristaMD CEO Brooke LeVasseur, 2018 Top 50 US CEOs

Brooke LeVasseur, CEO of AristaMD, has been included in Comparably‘s 2018 round-up of top 50 US CEOs.

“The most successful businesses are led by amazing CEOs who serve as visionaries, in addition to being positive examples and support systems for their teams,” said Jason Nazar, Comparably CEO. “The chief executives on Comparably’s Best CEOs list were the highest rated by employees for their inspiring, transparent, and engaging leadership.”

To spotlight which company leaders are the best in the U.S., Comparably compiled data using survey responses from employees at some of the nation’s largest companies that have 500 or more employees.

In total, Comparably received nearly 10 million ratings across 50,000 U.S. companies.

Other big names in the top 10 for large companies include Home Depot’s Craig Menear, Google’s Sundar Pichai, Amazon’s Jeff Bezos and Saleforce’s Marc Benioff.

Brooke LeVasseur

Brooke LeVasseur

CEO

Brooke LeVasseur is the CEO of AristaMD and has 20 years of leadership experience launching new, innovative healthcare products and solutions to payers and providers, including software and eConsult solutions. As an established entrepreneur and an innovative leader, Brooke has deep experience identifying, developing and launching new business offerings while managing teams to achieve operational goals. Her expertise spans the healthcare spectrum, from consumer health to devices and diagnostics.

Brooke has led teams to successfully commercialize new, innovative healthcare tools and gain widespread clinician adoption and reimbursement. She has held executive roles at Thomson Reuters, Veracyte and Sequenom, as well as an array of consultant roles at industry-leading investment and healthcare companies such as Kleiner Perkins Caufield & Byers, Versant Ventures, Illumina, Cypher Genomics and GRAIL.

Brooke spends her time outside work in the ocean or hanging out with her husband, two kids and two kittens.